Evofem Biosciences EVFM
OTC EVFM
$0.01 +0.00 (+0.00%)
At close: Oct 20, 2026 · 4:00 PM EDT

Evofem Biosciences (EVFM) Convertible Debt (2020 - 2021)

Updated

Evofem Biosciences (EVFM) posted Convertible Debt of $26.7 million for Q3 2021, up 1.9% from the prior quarter.

Analysis

Evofem Biosciences (EVFM) Convertible Debt (2020 - 2021) Analysis & Trends

At the end of FY2020, Evofem Biosciences' Convertible Debt came in at $25.21 million.

  • The Q3 2021 figure stands as the highest quarterly Convertible Debt since Q2 2020.
  • According to Business Quant data, Convertible Debt for the three prior quarters was $26.19 million (Q2 2021), $25.7 million (Q1 2021) and $25.21 million (Q4 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,171.71 Bn 1,140.30 Bn 19.71 Bn
2 Johnson & Johnson 642.13 Bn 560.65 Bn 17.26 Bn
3 AbbVie 501.64 Bn 474.75 Bn 12.70 Bn
4 Merck 375.66 Bn 330.04 Bn 12.21 Bn
5 Novartis Ag 302.79 Bn 266.78 Bn 11.24 Bn
6 Astrazeneca 268.68 Bn 242.37 Bn 12.86 Bn
7 Amgen 242.43 Bn 197.83 Bn 7.24 Bn
8 Gilead Sciences 193.69 Bn 167.89 Bn 6.22 Bn
9 Pfizer 172.47 Bn 119.12 Bn 10.94 Bn
10 Evofem Biosciences 1.33 Mn 1.33 Mn 2.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 26.70 Mn
Jun 30, 2021 26.19 Mn
Mar 31, 2021 25.70 Mn
Dec 31, 2020 25.21 Mn
Jun 30, 2020 58.10 Mn
API Access

Evofem Biosciences Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=EVFM&period=max&api_key=YOUR_API_KEY